• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

News

Article

SLIDESHOW: Showcasing Melanoma Research at the 56th Annual ACMS Meeting

Dozens of investigators shared findings to advance care in patients with melanoma during Mohs micrographic surgery.

slideshow image

The 56th Annual American College of Mohs Surgery (ACMS) Meeting kicked off Skin Cancer Awareness Month with the latest developments in cutaneous oncology and pathology, fundamentals of dermatologic surgery, advanced reconstruction, and more from May 2-5, 2024 in Phoenix, Arizona. Poster abstracts covered a wide range of topics, including advancements in melanoma management in 8 scientific research presentations.

References

  1. Badin D, Salem I, Feng J, et al.Analyzing rate of recurrences and new primary melanotic malignancies post melanoma in situ diagnosis: findings from a single-center study. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
  2. Juhasz M, Gharavi N. Cutaneous melanoma upstaging during Mohs micrographic surgery. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
  3. Read C, Armstrong A. Factors that impact patients’ satisfaction with their dermatological surgeons: a population study among u.s. adults with melanoma and non-melanoma cutaneous cancers who underwent a surgical procedure. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
  4. Moody B, Sudhaman S, Ferguson J, et al. Feasibility of using a tumor-informed circulating tumor DNA (ctDNA) test for clinical decision-making in patients with resectable stage II/III melanoma. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
  5. Asamoah E, Demer A, Vidal N, et al. Immunohistochemistry-assisted Mohs surgery for treatment of invasive eyelid and periorbital cutaneous melanoma: oncologic and reconstructive outcomes. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
  6. DaCunha M, Coldiron B, Tassavor M, Bland M. Improving melanoma reporting adherence: the melanoma reporting model. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
  7. Campbell E, Reinhart J, Proffer S, et al. Incidence and mortality trends of primary cutaneous melanoma: a 50-year population-based study. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
  8. Freeman S, Carr D, Shahwan K, Latour E, Leitenberger J. Margin assessment in Mohs for melanoma: evaluation of interrater and intrarater reliability. Poster presented at: 56th Annual ACMS Meeting. May 2-5, 2024; Phoenix, AZ.
© 2025 MJH Life Sciences

All rights reserved.